C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/11 (2006.01) C12N 15/62 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2143325
The present invention relates to the cloning of LAPP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzhei- mer's Disease.
Kozlowski Michael R.
Manly Susan P.
Neve Rachael L.
Bristol-Myers Squibb Company
Mclean Hospital Corporation
Osler Hoskin & Harcourt Llp
LandOfFree
Cloning and expression of .beta.app-c100 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning and expression of .beta.app-c100 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and expression of .beta.app-c100 receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2047715